Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1/2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Dermatologic 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Myelodysplastic Syndromes 12Lymphoma, Non-Hodgkin 11Hodgkin Disease 11Leukemia, Lymphocytic, Chronic, B-Cell 10Leukemia 10Multiple Myeloma 9Leukemia, Myelomonocytic, Chronic 9Leukemia, Myeloid, Accelerated Phase 9Lymphoma, Mantle-Cell 8Leukemia, Myeloid, Chronic-Phase 8Hematologic Neoplasms 8Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Lymphoma 7Myeloproliferative Disorders 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Biphenotypic, Acute 6Graft vs Host Disease 6Congenital Abnormalities 6Blast Crisis 6Waldenstrom Macroglobulinemia 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Carcinoma, Renal Cell 5Burkitt Lymphoma 5Anemia, Refractory, with Excess of Blasts 5Lymphoma, T-Cell, Cutaneous 4Recurrence 3

Interventions

Dexamethasone 4ruxolitinib 2pomalidomide 2daratumumab 2Tacrolimus 2Mycophenolic Acid 2Lenalidomide 2Cyclophosphamide 2Bortezomib 2sonidegib 1ricolinostat 1ponatinib 1nirogacestat 1fludarabine phosphate 1fludarabine 1dacetuzumab 1Vorinostat 1Stem Cell Transplantation 1Remifentanil 1Quality of Life 1Methotrexate 1Mesna 1Melphalan 1KW-2478 1Hsp90 inhibitor KU757 1Filgrastim 1Electrocardiography 1Cyclosporine 1Clinical Laboratory Techniques 1CPI-0610 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Hematologic Diseases × Mycophenolic Acid × Clear all
NCT05589896 2026-02-24

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

Ossium Health, Inc.

Phase 1/2 Recruiting
12 enrolled
Classical hematologyDermatologicLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Leukemia, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Cutaneous, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03842696 2026-01-27

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

University of Michigan Rogel Cancer Center

Phase 1/2 Active not recruiting
43 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Graft vs Host Disease, Hematologic Diseases, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡